Agnete B. Fredriksen

Joining forces with >60 leaders in immunology to encourage FDA to increase the focus on T cell responses in COVID-19 and infectious diseases in general.

Når grundertilværelsen føles ekstra meningsfull🌟 ringvirkninger.dnb.no/vis/990646066

We select our partners carefully! Enjoy the collaboration with the competent team at Adaptive Biotechnologies generating 3rd generations vaccines. Listen to the webcast at 4 pm today. bit.ly/36uEsEl

This is an amazing achievement by the entire Vaccibody family! Thanks to the patients, investigators, collaborators and all Vaccibody team members for the dedication to this important study. vaccibody.com/wp-content/upl…

Proud and excited for reaching this milestone! Rewarding to work with JZ and the rest of the Nektar team.

@eivindhaugan Never uncross, Eivind!!😉 Thanks for all your support.

@ABFredriksen Finally, now I can 'uncross' my fingers 🤞🖐️ Looking forward to get more insight into the results next week.

Very excited about the strong signs of vaccine-induces clinical responses, backed up with a range of scientificly sound correlations, in our cancer neoantigen vaccine trial! lnkd.in/eP4csKp #cancerresearch #cancervaccine #neoantigens

New times in Vaccibody! Thx to Martin for 4 great years! And a warm welcome to Michael! Ready for next phase💪🏼 vaccibody.com/organizational…

Thanks for the invite and opportunity to share my journey. Really enjoyed the entire program and the interactive discussions!

@eivindhaugan @Labiotech_eu She is very excited, Eivind:-)

@Labiotech_eu Did you get @ABFredriksen comments on the latest release of immunogenicity data that was sent out this afternoon? The data seems very promising to me, but I’m no scientist 🤔 vaccibody.com/vaccibody-anno…

Last fireside chat before our Panel! Wonderful to have @Vaccibody President & CSO Agnete Fredriksen sharing with us - “How to manage the #science of a #biotech company”!

🎤 Speaker #1 - We're thrilled to have Agnete Fredriksen @ABFredriksen, CSO of @Vaccibody, join us at Labiotech Insider Day! Take a sneak peek at the program & register today! 👉🏻 bit.ly/2KHPWLe 👈🏻 #biotech #LBRefresh

In San Francisco speaking at the Mol Med Tri-Con while TV2 tells about our Roche collaboration. Exciting days. tv2.no/nyheter/104662…

And then the 230 MNOK was secured! Thanks for the strong support and interest from our investors! vaccibody.com/sucessfully-cl…

Vaccibody is excited to announce a Collaboration With Roche combining VB10.16 and Atezolizumab in Cervical Cancer! vaccibody.com/vaccibody-as-r…

NRK EKKO har laget et flott radioinnslag om vår porteføljebedrift Vaccibody der @ABFredriksen forteller om hvordan de utvikler persontilpassede kreftvaksiner: #t=58m13.84s" target="_blank" rel="nofollow noopener">radio.nrk.no/serie/ekko#t=5… #helsenæring #kreft

Finansavisen lørdag- hvorfor er Vaccibody og Nektar så gode partnere?

We’ve entered into a new clinical collaboration with Vaccibody to combine their personalized neo-antigen cancer vaccine with NKTR-214. Learn more about this combination's design to harness specific T cell clonal expansion in the fight against cancer: bit.ly/2xqtkr6

So excited to announce this highly interesting clinical collaboration with Nektar Therapeutics! vaccibody.com/vaccibody-anno…

Trying to convince our Minister of Trade and Industry to create better incentiver for startup and founders:-) #timeforchange #startup #politicians

Ny pod er ute nå. @elikirand har besøk av @ABFredriksen og Martin Bonde fra vår porteføljebedrift #Vaccibody: Vi snakker om utviklingen av deres persontilpassede kreftvaksine og planer for framtiden soundcloud.com/user-972208711…